Brief: Annovis Bio Announces Issuance Of U.S. Patent Covering The Use Of Lead Drug Candidate, Buntanetap

Annovis Bio

27/04/2023 12:29

April 27 (Reuters) - Annovis Bio Inc  ANVS.N :
    * ANNOVIS BIO ANNOUNCES ISSUANCE OF U.S. PATENT COVERING THE
USE
OF LEAD DRUG CANDIDATE, BUNTANETAP, FOR PREVENTION OR TREATMENT
OF DISEASE STATES DUE TO METAL DIS-HOMEOSTASIS IN HEALTHY OR
SICK HUMANS

Source text for Eikon:  ID:nGNXbbVTG0 
Further company coverage:  ANVS.N 

 ((Reuters.Briefs@thomsonreuters.com;))